RTL
KRON

Red Tortoise LLC’s Kronos Bio KRON Stock Holding History

Red Tortoise LLC’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,062
Closed -$1.55K – 591
2023
Q1 		$1.55K Hold
1,062
– – ﹤0.01% 483
2022
Q4 		$1.72K Buy
+1,062
New +$2.44K ﹤0.01% 496
2021
Q4 		– Sell
-442
Closed -$1K – 308
2021
Q3 		$1K Buy
+442
New +$9.49K ﹤0.01% 506

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Red Tortoise LLC's KRON Position: Q2 2023 in Review

Red Tortoise LLC sold out of Kronos Bio (KRON) in Q2 2023, closing a stake of 1,062 shares — an estimated $1.55K sold.

Red Tortoise LLC first reported a position in KRON in Q3 2021 and held it in 3 quarters. The position peaked at $1.72K in Q4 2022. 80 funds tracked by Wall St. Rank hold KRON as of Q2 2023.

  • Red Tortoise LLC reported no remaining Kronos Bio position as of Q2 2023 after selling out during the quarter.
  • Red Tortoise LLC sold 1,062 Kronos Bio shares in Q2 2023, an estimated $1.55K.
  • Red Tortoise LLC first reported a position in Kronos Bio in Q3 2021 and held it in 3 quarters.
  • Red Tortoise LLC's Kronos Bio position peaked at $1.72K in Q4 2022.
  • 80 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2023.

Based on Red Tortoise LLC's 13F filing for Q2 2023, filed 26 Jul 2023.